Results

Total Results: 455 records

Showing results for "malignant neoplasm".

241. Nis 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
     January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies

242. Kid 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
     January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R

243. Nis 2013 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
     January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies

244. Understanding and Analyzing MEPS Household Component Medical Condition Data (pdf file)
     meps.ahrq.gov/survey_comp/MEPS_condition_data.pdf
     January 01, 2009 - include high blood pressure, heart disease, stroke, emphysema, chronic bronchitis, high cholesterol, cancer … diseases  1,993  75.2  12.5  12.4  10, 254–258  Other care and screening  1,866  84.6  2.7  12.7  11–45  Cancer …   1,321  89  1.2  9.9  46, 47  Non‐malignant neoplasm  381  83.6  1.7  14.7  48  Thyroid disease  1,285 … 625,421 14 10, 254–258  Other care and screening 20,347,107 931,518 16 17,219,615 808,617 13 11–45  Cancer … 17,400,124 736,081 19 15,479,928 709,324 17 46, 47  Non-malignant neoplasm 4,708,789 327,107 37 3,936,964

245. Archived: Ovarian Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-1996
     January 01, 1996 - cancer appear to be more effective in reducing the size of residual tumor when ovarian cancer is detected … invasive procedures (laparoscopy or laparotomy) to rule out malignancy. … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. … Detection of malignant ovarian neoplasm[s]: a review of the literature. 1. … Elevated serum CA 125 levels prior to diagnosis of ovarian cancer neoplasia: relevance for early detection

246. Maskedstats Nrd 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
     October 31, 2017 - electrolyte disorders 12,927,179 0 0.00 1.00 0.24 0.43 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 12,927,179 0 0.00 1.00 0.12 0.33 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 9,988 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 6,987 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 8,696 0.07% 690 … Percent of Total 692: Radiotherapy 855 0.01% 693: Chemotherapy 53,580 0.41% 694: Lymphatic & other malignancies

247. Nrd 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
     January 01, 2014 - electrolyte disorders 14,894,613 0 0.00 1.00 0.23 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,894,613 0 0.00 1.00 0.12 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,999 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,074 0.01% 693: Chemotherapy 63,030 0.42% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 11,821 0.08% 710: Infectious & parasitic diseases including HIV w

248. Nis 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
     January 01, 2012 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,296,968 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,994 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,605 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,755 0.07% 690 … Percent of Total 692: Radiotherapy 706 0.01% 693: Chemotherapy 31,632 0.43% 694: Lymphatic & other malignancies

249. Nis 1998 Summarystats Core10A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
     January 01, 1998 - cancer of skin 122 0.02 24: Cancer of breast 2353 0.34 25: Cancer of uterus 753 0.11 26: Cancer of … : Cancer of prostate 1733 0.25 30: Cancer of testis 37 0.01 31: Cancer of other male genital organs … , other Unspecified primary 186 0.03 42: Secondary malignancies 5145 0.75 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3772 0.55 46: Benign neoplasm of uterus 4448 0.65 47: Other … unspecified benign neoplasm 2893 0.42 48: Thyroid disorders 715 0.10 49: Diabetes mellitus without

250. User Guide (v2025.1) for Clinical Classifications Software Refined (CCSR) for ICD-10-CM (pdf file)
     hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2025-1.pdf
     November 01, 2024 - status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm … Neoplasms NEO NEO contains 78 categories specific to neoplasms, which include malignant neoplasms … such as gastrointestinal cancers, skin cancers, and breast cancer, as well as most benign neoplasms … The Neoplasms body system follows the National Cancer Institute (NCI)8 organization of cancer types … status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm

251. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
     March 01, 2008 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348

252. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
     September 27, 2012 - die with hepatic metastases.1 Colorectal cancer is the most common malignancy that metastasizes to … "[Mesh] OR ((hepatic OR liver) AND (cancer OR cancers OR oncology OR neoplasms)) AND "Colorectal Neoplasms … OR cancers OR oncology OR neoplasms AND colon OR colorectal OR rectal OR intestinal OR rectum OR intestine … Is Extended Hepatectomy for Hepatobiliary Malignancy Justified? Ann Surg 2004;239(5):722-32. … Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.

253. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
     August 22, 2008 - KQ 5: What is the risk of malignancy associated with rhGH use as determined by: a) markers of cancer … decreases over 1000 ng/ml) from studies of rhGH in people with CF and by b) assessment of evidence on cancer … Neoplasms/ 39. neoplas$.mp. 40. malignan$.mp. 41. cancer.mp. 42. tumor.mp. 43. … Neoplasms/ 14. neoplas$.mp. 15. malignan$.mp. 16. cancer.mp. 17. tumor.mp. 18. … Neoplasms/ 46. neoplas$.mp. 47. malignan$.mp. 48. cancer.mp. 49. tumor.mp. 50.

254. Evidence Summary: Bladder Cancer in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/bladder-cancer-in-adults-screening
     October 15, 2010 - tissue) tumors. … 25% present as invasive tumors 12 . … invasive tumor 7 . … tumor marker. … / exp Urinary Bladder Neoplasms/di exp Urinary Bladder Neoplasms/ge exp "Sensitivity and Specificity

255. The Medical Expenditure Panel Survey is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States.
     meps.ahrq.gov/survey_comp/MEPS_condition_data.shtml
     January 01, 2009 - include high blood pressure, heart disease, stroke, emphysema, chronic bronchitis, high cholesterol, cancer … 12.5 12.4 10, 254–258 Other care and screening 1,866 84.6 2.7 12.7 11–45 Cancer … 1,321 89.0 1.2 9.9 46, 47 Non-malignant neoplasm 381 83.6 1.7 14.7 48 … 258 Other care and screening 20,347,107 931,518 16 17,219,615 808,617 13 11–45 Cancer … 17,400,124 736,081 19 15,479,928 709,324 17 46, 47 Non-malignant neoplasm 4,708,789

256. Imaging Techniques for the Surveillance, Diagnosis, and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/liver-cancer/research-protocol

257. Medical Care for Adults with Down Syndrome (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
     July 09, 2024 - cancersb Solid tumor cancers, including breast, prostate, testicular, cervical, and colon cancer. … Low risk of solid tumors in persons with Down syndrome. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or (hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?

258. Medical Care for Adults with Down Syndrome (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
     February 05, 2025 - cancersb Solid tumor cancers, including breast, prostate, testicular, cervical, and colon cancer. … Low risk of solid tumors in persons with Down syndrome. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or (hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?

259. head-neck-cancer-update-140204 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
     February 04, 2014 - Cancer Network.2 The consensus definition of head and neck cancer includes tumors of: • larynx; … cancer; • esophageal cancer; and • trachea tumors. … [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours [TIAB] OR cancer [TIAB] OR cancers … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [

260. Icd-10 Dxccs Trends112817 (pdf file)
     hcup-us.ahrq.gov/datainnovations/ICD-10_DXCCS_Trends112817.pdf
     November 28, 2017 - 0.8 –2.9 43: Malignant neoplasm without specification of site 1,064 1,072 1,308 0.8 22.0 44: … 18,167 22,433 8.4 23.5 43: Malignant neoplasm without specification of site 4,728 4,931 3,062 4.3 … 45: Maintenance chemotherapy; radiotherapy 500 606 834 21.2 37.6 46: Benign neoplasm of uterus … 15,610 17,381 17,512 11.3 0.8 47: Other and unspecified benign neoplasm 20,852 23,784 22,214 14.1 … of pancreas 2,592 2,994 3,019 15.5 0.8 46: Benign neoplasm of uterus 15,610 17,381 17,512 11.3 0.8